FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Special Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities and Exchange Act of 1934
For the date of November 19, 2002
Centerpulse Ltd.
(Translation of registrant's name into English)
Andreasstrasse 15
CH-8050 Zurich
Switzerland
(Address of principal executive office)
(Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.)
Form 20-F X Form 40-F
(Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.)
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .)
Centerpulse Ltd. is filing this Report on Form 6-K to furnish the media release regarding the completion of the sale of Vascutek Ltd. and IntraTherapeutics Inc., which media release is attached hereto as Exhibit 99.1.
Centerpulse Ltd. hereby incorporates this Report on Form 6-K by reference into the Registration Statements on Form S-8, No. 33-8300, No. 333-76280 and No. 333-85388.
| 99.1 | Media Release, dated November 18, 2002, announcing that Centerpulse Ltd. has completed the sales of Vascutek Ltd. and IntraTherapeutics Inc. |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
| CENTERPULSE LTD. | |||
By: |
/s/ DAVID S. WISE David S. Wise Authorized Representative |
Date: November 19, 2002
3
| Exhibit |
Description |
|
|---|---|---|
| 99.1 | Media Release, dated November 18, 2002, announcing that Centerpulse Ltd. has completed the sales of Vascutek Ltd. and IntraTherapeutics Inc. |
4